Viewing Study NCT06967961


Ignite Creation Date: 2025-12-24 @ 12:05 PM
Ignite Modification Date: 2026-01-01 @ 7:28 AM
Study NCT ID: NCT06967961
Status: RECRUITING
Last Update Posted: 2025-07-29
First Post: 2025-05-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers
Sponsor: Institut Claudius Regaud
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module